Treatment of Intimate Partner Violence and Substance Abuse in a Forensic Setting

September 16, 2013 updated by: Paul M.G.Emmelkamp, VU University of Amsterdam
Intimate partner violence is a significant societal problem. However, treatment of IPV perpetrators is far from effective, which may be partly due to the fact that the role of substance abuse is not taken into account. There is considerable evidence that a strong relationship between the use of alcohol and other drugs and intimate partner violence exists. Besides, a few studies indicate that reducing substance use may have a positive impact on IPV. Therefore, in this study, perpetrators of intimate partner violence with substance use disorders enrolled in domestic violence treatment will be randomly assigned to either standard treatment for offenders of domestic violence or a combination of the latter treatment with cognitive-behavioral therapy addressing substance abuse (combined treatment).

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Netherlands
      • Amsterdam / Rotterdam, Netherlands, 1018AJ
        • De Waag Amsterdam & Rijnmond

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • A history of perpetration of intimate partner violence
  • Current alcohol, cannabis and/or cocaine abuse or dependence
  • Still in an intimate relationship with the victim

Exclusion Criteria:

  • Not sufficient fluency in Dutch to complete treatment and measures
  • (ab)use of crack cocaine and/or heroin
  • In need of clinical detoxification
  • Severe mental disorders, such as psychosis
  • Severe cognitive disorders, such as Korsakoff's syndrome
  • In treatment for other mental health problems
  • Abuse of children

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: combined treatment
A combined treatment containing cognitive behavioral therapy addressing partner violence and cognitive behavioral therapy addressing substance abuse
Behavioral: substance abuse/domestic violence treatment
This intervention is comprised of 16 sessions of cognitive behavioral therapy. 8 sessions are addressing partner violence and 8 sessions are addressing substance abuse.
Active Comparator: control condition
Cognitive behavioral therapy addressing partner violence
Behavioral: CBT addressing partner violence
This treatment is comprised of 16 sessions of cognitive behavioral therapy addressing partner violence.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quick Drinking Screen (QDS)
Time Frame: pretest, posttest, 6 & 12 months follow-up
pretest, posttest, 6 & 12 months follow-up
Conflict Tactics Scale (CTS)
Time Frame: pretest, halfway treatment, posttest, 6 & 12 months follow-up
pretest, halfway treatment, posttest, 6 & 12 months follow-up
Timeline Followback interview
Time Frame: pretest, posttest
Assesses daily substance use in the past 4 months
pretest, posttest

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brief Symptom Inventory (BSI)
Time Frame: pretest, posttest, 6 and 12 moths follow-up
Assesses general psychological complaints
pretest, posttest, 6 and 12 moths follow-up
Maudsly Marital Questionnaire (MMQ)
Time Frame: pretest, posttest, 6 and 12 months follow up
Assesses marital satisfaction
pretest, posttest, 6 and 12 months follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

VU University of Amsterdam

Investigators

  • Principal Investigator: Paul M.G. Emmelkamp, PhD., University of Amsterdam

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2010

Primary Completion (Anticipated)

April 1, 2014

Study Completion (Anticipated)

April 1, 2014

Study Registration Dates

First Submitted

February 18, 2009

First Submitted That Met QC Criteria

February 18, 2009

First Posted (Estimate)

February 19, 2009

Study Record Updates

Last Update Posted (Estimate)

September 17, 2013

Last Update Submitted That Met QC Criteria

September 16, 2013

Last Verified

September 1, 2013

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2008-KP-463

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe